Arteriovenous malformations (AVMs) are abnormal and direct connections between arteries and veins, causing disorganised blood flow and weak vessel structure. Although nosebleeds are a common clinical outcome of AVMs, more serious hemorrhages in the brain and lungs can occur. Corti et al. studied AVMs in zebrafish embryos carrying a mutant version of activin receptor-like kinase 1 (alk1), which is associated with hemorrhagic telangiectasia type 2 (HTT2), a vascular disorder characterised by AVMs. In the absence of functional Alk1, initial increases in endothelial cell number cause arteries nearest to the embryonic heart to become enlarged, increasing blood flow to downstream vessels, which then compensate by stabilising normally transient arteriovenous connections, consequently generating AVMs. The authors also found that alk1 expression requires blood flow, suggesting that the protein functions as a sensor of shear stress to limit vessel size. These results provide insight into the etiology of HTT2-associated AVMs and open up new avenues for therapeutic intervention.
alk1 mutant zebrafish shed light on the etiology of AVMs Open Access
alk1 mutant zebrafish shed light on the etiology of AVMs. Dis Model Mech 1 May 2011; 4 (3): 278. doi:
Download citation file:
Advertisement
Cited by
Call for papers – In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery

We invite you to submit your latest research to our upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery, coordinated by DMM Editor Vivian Li (The Francis Crick Institute, London, UK), alongside Guest Editors Austin Smith (University of Exeter, UK) and Joseph Wu (Stanford University School of Medicine, USA).The deadline for submitting articles is 6 October 2025.
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
Propose a new Workshop for 2027

We are currently seeking proposals for Workshops to be held in 2027. As one of the scientific organisers of a The Company of Biologists Workshop, your involvement will be focused on interdisciplinary, cutting-edge science and promoting new partnerships and collaborations. We focus on the logistics. Are you thinking about proposing a topic for one of our Workshops? Apply by Friday 30 May 2025.
Other journals from
The Company of Biologists